Gordan Lauc at ARDD2026: IgG glycans as modifiable biomarkers of biological age
Thumbnail from YouTube. Playing loads the YouTube player.
History & recommendationsOff
Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.
Open saved items & history →At a glance
Automatic summary · not editorially reviewedIn the supplied description, Gordan Lauc's ARDD2026 talk is said to present IgG glycans as modifiable biomarkers that track biological age, predict disease years ahead and act as effectors of inflammation. The description does not report study data. [1]
The description attributes to Gordan Lauc the takeaway that IgG glycans are modifiable biomarkers tracking biological age, predicting disease years ahead and acting as effectors of inflammation. [1]
The talk title as given moves from individualized monitoring to targeted intervention, without the description naming tested interventions or outcomes. [1]
The description says ARDD2026 was held in Boston at Harvard University on October 1-3, 2026. [1]
Lauc's described IgG glycan takeaway
The description attributes one key takeaway to Gordan Lauc of the University of Zagreb for his ARDD2026 talk: IgG glycans are modifiable biomarkers that track biological age, predict disease years ahead and act as effectors of inflammation. These are claims about measurement and prediction, not evidence that changing glycans changes lifespan or prevents disease. The description gives no numbers, study design or comparison groups. [1]
Monitoring and intervention framing in the talk
The talk title, as given in the description, moves from individualized monitoring to targeted intervention. The description does not say which interventions were tested, in whom, or with what outcomes. The word modifiable therefore describes the biomarkers as changeable, not a demonstrated treatment effect. [1]
ARDD2026 venue and description-only scope
The description states that ARDD2026 took place in Boston at Harvard University on October 1-3, 2026, after years of growth in Europe, and was organized by Insilico Medicine with listed sponsors. It does not report the talk's methods, sample or results. This explainer relies only on the description; the video and transcript were not reviewed. [1]
Context & limits
Only the video description was available; the video and transcript were not reviewed. The description gives no study design, sample, numbers, follow-up or comparator, so the biomarker claims cannot be checked here.
Based on the creator’s description; the full video and transcript were not analyzed.
Quoted passages in the original language
IgG glycans are modifiable biomarkers that track
From Individualized Monitoring to Targeted Intervention
on October 1-3, 2026
About this video
Creator description · original textText language: English
ARDD · 25 min · Source published: 2026-10-19
Added to Harbor: 10/23/2026
Original on YouTube ↗Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.